Buradasınız

BENEFICIAL EFFECT OF LOW DOSE AMLODIPINE VS NIFEDIPINE ON SERUM CHOLESTEROL PROFILE OF RABBITS RECEIVING STANDARD DIET

BENEFICIAL EFFECT OF LOW DOSE AMLODIPINE VS NIFEDIPINE ON SERUM CHOLESTEROL PROFILE OF RABBITS RECEIVING STANDARD DIET

Journal Name:

Publication Year:

Abstract (2. Language): 
Objective: To investigate the effect of low dose amlodipine v/s nifedipine on serum cholesterol profile of rabbits receiving standard diet. Methods: Fourty Newzealand rabbits were selected for the study. Their cholesterol profile was estimated at the beginning of the study. Rabbits were grouped into 4 groups receiving standard diet (control group), standard diet + vehicle propylene glycol, standard diet + nifedipine dissolved in propylene glycol and standard diet + amlodipine dissolved in propylene glycol. Along with standard diet they were treated with respective drugs for ten weeks. At the end of ten weeks serum cholesterol profile was estimated. Results: The cholesterol profile was estimated at the beginning and at the end of ten weeks. Total cholesterol in the amlodipine group decreased from 97±4.06 mg/dl to 90±4.2 mg/dl and HDL-Cholesterol increased from 32.01±4.40 mg/dl to 37±4.60 mg/dl after 10 week treatment but these changes were not significant. LDL cholesterol decreased significantly in rabbits with low dose of amlodipine from 55.42±3.32 mg/dl to 32.40±3.22 mg/dl and. In the nifedipine group there was a slight increase in total cholesterol from 102.49±5.16 mg/dl to 106±5.39 mg/dl, HDL cholesterol from 34.10±2.80 to 35.16±2.82 mg/dl and LDL cholesterol also increased from 56.20±2.20 mg/dl to 59.00±2.20 mg/dl after 10 week treatment. Conclusion: The study shows amlodipine produces favorable alterations in serum cholesterol profile.
47-51

REFERENCES

References: 

1. Johnson BF and Margaret A, Danylchuk. The
relevance of plasma lipid changes with
cardilovascular drug therapy. Medical Clinics
of North Americ.1989;73 (2):68
2. Castelli W.P. Anderson K: A population at risk
prevalence of high cholesterol levels in the
Framingham study Am. J. Medi 1980;80: 23-
32.
3. Dzaw VJ. Mechanism of interaction of
hypertension hypercholesterolemia in
atherogenesis. The effect of antihypertensive
agents Am. Heart jour. 1988; 17:25-29
4. Claude K, Lardinosis MD, Sherry LN. The
effects antihypertensive agents on serum
lipid profile Arch Internal
Medi.1988;148:1280-88
5. Ferrari P, Romsson J, Weidnann P:
Antihypertesive agents, serum lipoproteins
glucose metabolism Am. J.Cardio. 1991, April
22; 67 (10); 26-35.
6. Gotto Jr HM. Calcium channel blockers and
prevention of atherosclerosis. Am. J.
Hypertension.1990; 3: 3465-68.
7. Henry D. Antiatherosclerotic property of
calcium channel blockers possible mechanism
of action. Cardiovascular Drugs Ther.1990;
4:1015-20
8. Henry PD., Bentley KL.: Suppression of
antherogensis in cholesterol fed rabbits treated
with nifedipine. J. Clin. Invest. 1981; 68:1306-
9.
9. Jaju JB., Moholkar AL., Rahul AR. Lipid
profile in hypertension with special reference
to propranolol and atenolol. Indian medical
gazette-may 1998;32: (5): 132-34
10. Mehta JL. et al: Double blind evaluation of the
dose response relationship of amlodipine in
essential hypertension. Am. Heart J., 1993,125
(6): 1704-10
50
Bavane DS et al., Int J Med Res Health Sci.2013;2(1):47-51
11. National cholesterol education program panel
on detection, evaluation and treatment of high
blood cholesterol in adults. Arc. Intern .Med.,
1988;148:36-69.
12. Ohata N, Nagano K. Low-Density lipoprotein
lowering and high-density lipoprotein elevating
effects of nicardipine in rats. Bichem.
Pharmacol., 1984;33:2199-205.
13. Shephered J, Cobbe SM, Ford et al: Prevention
of coronary heart disease with pravastatin in
men with hypercholesterolemia. N.Engl. Med.
1995; 33:1301-7
14. Swain TR, Das, Kanungo S, Patanaik J:
Beneficial effects of low dose felodipine on
serum cholesterol of rabbits fed on atherogenic
diet. Indian Journal of Pharmacology, 1996;
27:133-35
15. Vos JW. Retardation and arrest of progression
or regression of coronary artery disease, A
review program, Cardiovasac Dis.
1991;35:435-54.

Thank you for copying data from http://www.arastirmax.com